Avanza Fonder’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,252
Closed -$80.5K 463
2024
Q4
$80.5K Buy
+2,252
New +$80.5K ﹤0.01% 427